Kringle Pharma
Kringle Pharma, Inc.
Osaka, Japan · Founded 2001 · $3.8M raised
- Headquarters
- Osaka
- Employees
- 11–50
- Founded
- 2001
- Business Model
- B2B
- Website
- kringle-pharma.com
- Total Funding
- $3.8M
- Last Round
- $3.8M Venture RoundDec 2016
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Kringle Pharma develops recombinant human HGF protein therapies for intractable diseases including acute spinal cord injury, ALS, and kidney injury.
Summary
Kringle Pharma is a Biotech company based in Osaka, Japan, founded in 2001. It has raised $3.8M in total across 1 round, most recently a $3.8M Venture Round in Dec 2016. Investors include DBJ Capital Corporation and Keio Innovation Initiative.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Dec 2016
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/kringle-pharma"><img src="https://indexed.vc/api/badge/company/kringle-pharma" alt="Kringle Pharma on Indexed.vc" width="260" height="76" /></a>